Bone mass is inversely proportional to Dkk1 levels in mice

Bone

Volumn 41, Issue 3, 2007, Pages 331-339

  MacDonald, Bryan T ^a   Joiner, Danese M ^b   Oyserman, Sivan M ^b   Sharma, Parul ^a   Goldstein, Steven A ^b   He, Xi ^a   Hauschka, Peter V ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bone; Dickkopf1; Mice; Microcomputed tomography; Wnt LRP5

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PROTEIN DICKKOPF 1; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ALLELE; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; CALVARIA; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; FEMALE; FEMUR; GENOTYPE; HOMEOSTASIS; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE MUTANT; MUTATION; NEWBORN; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKULL; TRABECULAR BONE;

ANIMALS; BONE AND BONES; BONE DENSITY; FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, MUTANT STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547561383     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.05.009     Document Type: Article

References (56)

1. Nusse R. Wnt signaling in disease and in development. Cell Res. 15 (2005) 28-32
2. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
3. Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 407 (2000) 530-535
4. He X., Semenov M., Tamai K., and Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131 (2004) 1663-1677
5. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107 (2001) 513-523
6. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H., Glass II D.A., et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157 (2002) 303-314
7. Little R.D., Carulli J.P., Del Mastro R.G., Dupuis J., Osborne M., Folz C., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70 (2002) 11-19
8. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346 (2002) 1513-1521
9. Babij P., Zhao W., Small C., Kharode Y., Yaworsky P.J., Bouxsein M.L., et al. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 18 (2003) 960-974
10. Akhter M.P., Wells D.J., Short S.J., Cullen D.M., Johnson M.L., Haynatzki G.R., et al. Bone biomechanical properties in LRP5 mutant mice. Bone 35 (2004) 162-169
11. Holmen S.L., Giambernardi T.A., Zylstra C.R., Buckner-Berghuis B.D., Resau J.H., Hess J.F., et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J. Bone Miner. Res. 19 (2004) 2033-2040
12. Hartmann C.A. Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 16 (2006) 151-158
13. Hu H., Hilton M.J., Tu X., Yu K., Ornitz D.M., and Long F. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132 (2005) 49-60
14. Hill T.P., Spater D., Taketo M.M., Birchmeier W., and Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8 (2005) 727-738
15. Day T.F., Guo X., Garrett-Beal L., and Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8 (2005) 739-750
16. Rodda S.J., and McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133 (2006) 3231-3244
17. Glass II D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8 (2005) 751-764
18. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., et al. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem. 280 (2005) 21162-21168
19. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
20. Jackson A., Vayssiere B., Garcia T., Newell W., Baron R., Roman-Roman S., et al. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 36 (2005) 585-598
21. Krishnan V., Bryant H.U., and Macdougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116 (2006) 1202-1209
22. Bodine P.V., Zhao W., Kharode Y.P., Bex F.J., Lambert A.J., Goad M.B., et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18 (2004) 1222-1237
23. Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280 (2005) 19883-19887
24. Semenov M., Tamai K., and He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 280 (2005) 26770-26775
25. Balemans W., Ebeling M., Patel N., Van Hul E., Olson P., Dioszegi M., et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10 (2001) 537-543
26. Brunkow M.E., Gardner J.C., Van Ness J., Paeper B.W., Kovacevich B.R., Proll S., et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68 (2001) 577-589
27. Balemans W., Patel N., Ebeling M., Van Hul E., Wuyts W., Lacza C., et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39 (2002) 91-97
28. Staehling-Hampton K., Proll S., Paeper B.W., Zhao L., Charmley P., Brown A., et al. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am. J. Med. Genet. 110 (2002) 144-152
29. Semenov M.V., and He X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J. Biol. Chem. 281 (2006) 38276-38284
30. Glinka A., Wu W., Delius H., Monaghan A.P., Blumenstock C., and Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391 (1998) 357-362
31. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411 (2001) 321-325
32. Bafico A., Liu G., Yaniv A., Gazit A., and Aaronson S.A. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol. 3 (2001) 683-686
33. Semenov M.V., Tamai K., Brott B.K., Kuhl M., Sokol S., and He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. 11 (2001) 951-961
34. Mao B., Wu W., Davidson G., Marhold J., Li M., Stannek P., et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417 (2002) 664-667
35. Mukhopadhyay M., Shtrom S., Rodriguez-Esteban C., Chen L., Tsukui T., Gomer L., et al. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev. Cell 1 (2001) 423-434
36. Adamska M., MacDonald B.T., and Meisler MH. Doubleridge, a mouse mutant with defective compaction of the apical ectodermal ridge and normal dorsal-ventral patterning of the limb. Dev. Biol. 255 (2003) 350-362
37. MacDonald B.T., Adamska M., and Meisler M.H. Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6. Development 131 (2004) 2543-2552
38. Monaghan A.P., Kioschis P., Wu W., Zuniga A., Bock D., Poustka A., et al. Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech. Dev. 87 (1999) 45-56
39. Li J., Sarosi I., Cattley R.C., Pretorius J., Asuncion F., Grisanti M., et al. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39 (2006) 754-766
40. Zhang Y., Wang Y., Li X., Zhang J., Mao J., Li Z., et al. The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol. Cell. Biol. 24 (2004) 4677-4684
41. Li X., Liu P., Liu W., Maye P., Zhang J., Zhang Y., et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat. Genet. 37 (2005) 945-952
42. Morvan F., Boulukos K., Clement-Lacroix P., Roman Roman S., Suc-Royer I., Vayssiere B., et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res. 21 (2006) 934-945
43. Schmittgen T.D. Real-time quantitative PCR. Methods 25 (2001) 383-385
44. Volkman S.K., Galecki A.T., Burke D.T., Paczas M.R., Moalli M.R., Miller R.A., et al. Quantitative trait loci for femoral size and shape in a genetically heterogeneous mouse population. J. Bone Miner. Res. 18 (2003) 1497-1505
45. Favier B., Rijli F.M., Fromental-Ramain C., Fraulob V., Chambon P., and Dolle P. Functional cooperation between the non-paralogous genes Hoxa-10 and Hoxd-11 in the developing forelimb and axial skeleton. Development 122 (1996) 449-460
46. Loots G.G., Kneissel M., Keller H., Baptist M., Chang J., Collette N.M., et al. Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res. 15 (2005) 928-935
47. Wellik D.M., and Capecchi M.R. Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton. Science 301 (2003) 363-367
48. Hamrick M.W., McPherron A.C., Lovejoy C.O., and Hudson J. Femoral morphology and cross-sectional geometry of adult myostatin-deficient mice. Bone 27 (2000) 343-349
49. Beamer W.G., Donahue L.R., Rosen C.J., and Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone 18 (1996) 397-403
50. Wergedal J.E., Sheng M.H., Ackert-Bicknell C.L., Beamer W.G., and Baylink D.J. Genetic variation in femur extrinsic strength in 29 different inbred strains of mice is dependent on variations in femur cross-sectional geometry and bone density. Bone 36 (2005) 111-122
51. Sheng M.H., Lau K.H., Mohan S., Baylink D.J., and Wergedal J.E. High osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is associated with low apoptosis in C3H/HeJ osteoblasts. Calcif. Tissue Int. 78 (2006) 293-301
52. Sawakami K., Robling A.G., Ai M., Pitner N.D., Liu D., Warden S.J., et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem. 281 (2006) 23698-236711
53. Pinson K.I., Brennan J., Monkley S., Avery B.J., and Skarnes WC. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407 (2000) 535-538
54. Kokubu C., Heinzmann U., Kokubu T., Sakai N., Kubota T., Ozono K., et al. Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 131 (2004) 5469-5480
55. Mani A., Radhakrishnan J., Wang H., Mani A., Mani M.A., Nelson-Williams C., et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315 (2007) 1278-1282
56. Carter M., Chen X., Slowinska B., Minnerath S., Glickstein S., Shi L., et al. Crooked tail (Cd) model of human folate-responsive neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12843-12848